GENERATION AND CHARACTERISATION OF CISPLATIN-RESISTANT NON-SMALL CELL LUNG CANCER CELL LINES DISPLAYING STEM-LIKE FEATURES

被引：0
|
作者：
Barr, Martin P. [1 ]
Fennell, Dean A. [2 ]
O'Byrne, Kenneth J. [1 ]
机构：
[1] St James Hosp, Trinity Coll Dublin, Dublin, Ireland
[2] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT7 1NN, Antrim, North Ireland
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
NSCLC; Cisplatin resistance; stem cells;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S676 / S677
页数：2
相关论文
共 50 条
  • [41] KRAS and EGFR Mutations Differentially Alter ABC Drug Transporter Expression in Cisplatin-Resistant Non-Small Cell Lung Cancer
    Jaromi, Luca
    Csongei, Veronika
    Vesel, Monika
    Abdelwahab, ElHusseiny Mohamed Mahmud
    Soltani, Amina
    Torok, Zsofia
    Smuk, Gabor
    Sarosi, Veronika
    Pongracz, Judit Erzsebet
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (10)
  • [42] Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines
    La Monica, Silvia
    Galetti, Maricla
    Alfieri, Roberta R.
    Cavazzoni, Andrea
    Ardizzoni, Andrea
    Tiseo, Marcello
    Capelletti, Marzia
    Goldoni, Matteo
    Tagliaferri, Sara
    Mutti, Antonio
    Fumarola, Claudia
    Bonelli, Mara
    Generali, Daniele
    Petronini, Pier Giorgio
    BIOCHEMICAL PHARMACOLOGY, 2009, 78 (05) : 460 - 468
  • [43] SOX9 regulates cancer stem-like cells and chemotherapy response in non-small cell lung cancer
    Voronkova, Maria
    Luanpitpong, Sudjit
    Rojanasakul, Yon
    CANCER RESEARCH, 2018, 78 (13)
  • [44] Metformin enhances the radiosensitizing effect of cisplatin in non-small cell lung cancer cell lines with different cisplatin sensitivities
    Muhammad Assad Riaz
    Ali Sak
    Yasin Bahadir Erol
    Michael Groneberg
    Jürgen Thomale
    Martin Stuschke
    Scientific Reports, 9
  • [45] Metformin enhances the radiosensitizing effect of cisplatin in non-small cell lung cancer cell lines with different cisplatin sensitivities
    Riaz, Muhammad Assad
    Sak, Ali
    Erol, Yasin Bahadir
    Groneberg, Michael
    Thomale, Jurgen
    Stuschke, Martin
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [46] Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through p21 and cyclin D1-mediated tumour cell inhibition in non-small cell lung cancer cell lines
    Baharuddin, Puteri
    Satar, Nazilah
    Fakiruddin, Kamal Shaik
    Zakaria, Norashikin
    Lim, Moon Nian
    Yusoff, Narazah Mohd
    Zakaria, Zubaidah
    Yahaya, Badrul Hisham
    ONCOLOGY REPORTS, 2016, 35 (01) : 13 - 25
  • [47] Intrapleural combination bevacizumab with cisplatin therapy for non-small cell lung cancer caused by non-small cell lung cancer
    Du, Nan
    Zhao, Hui
    Wang, Haibin
    Li, Xiaosong
    Ma, Junxun
    Fan, Zhongyi
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [48] Lung Tumorspheres Characterization Reveals Cancer Stem-Like Cells Potential Targets and Prognostic Markers in Non-Small Cell Lung Cancer
    Herreros-Pomares, A.
    Jantus-Lewintre, E.
    Calabuig-Farinas, S.
    De-Maya-Girones, J. D.
    Lucas, R.
    Blasco, A.
    Guijarro, R.
    Martorell, M.
    Escorihuela, E.
    Chiara, M. D.
    Durendez-Saez, E.
    Gandia, C.
    Sirera, R.
    Farras, R.
    Camps, C.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S261 - S261
  • [49] Characterization of lung tumourspheres reveals cancer stem-like cells potential targets and prognostic markers in non-small cell lung cancer
    Herreros Pomares, A.
    Jantus-Lewintre, E.
    Calabuig-Farinas, S.
    de-Maya-Girones, J. D.
    Lucas, R.
    Blasco, A.
    Guijarro, R.
    Martorell, M.
    Escorihuela, E.
    Alonso, S.
    Chiara, M. D.
    Durendez, E.
    Gandia, C.
    Sirera, R.
    Farras, R.
    Camps, C.
    ANNALS OF ONCOLOGY, 2019, 30 : 587 - 587
  • [50] Non-cross resistance of ZD0473 in acquired cisplatin-resistant lung cancer cell lines
    Kawamura-Akiyama, Y
    Kusaba, H
    Kanzawa, F
    Tamura, T
    Saijo, N
    Nishio, K
    LUNG CANCER, 2002, 38 (01) : 43 - 50
12345